Genmab's deal with Glaxo worth up to &#36;2B
108565
Danish biotech Genmab A/S on Tuesday signed a deal worth up to $2.1 billion with pharmaceutical company GlaxoSmithKline PLC for the global commercialization of a leukemia treatment.
595051
U.S. health officials agreed to buy  1.2 million doses of influenza vaccine made by GlaxoSmithKline  on Tuesday and said another 2.8 million doses from the company  will be available later during the flu season.
110931
na settlement that the New York State attorney general said would transform the drug industry, GlaxoSmithKline agreed today to post on its Web site the results of all clinical trials involving its drugs.
640929
Shares of Cambridge-based Genzyme were up slightly today on news that the drug maker won approval for a drug to treat childhood leukemia.
549383
THE REGION Genzyme Corp. , maker of enzyme therapies for rare diseases, had a loss in the fourth quarter on acquisition costs but expects higher sales in 2007. The net loss was $268.2 million, or $1.02 a share, versus net income of $106.6 million, or 39 cents, a year earlier, the Cambridge company said. Profit excluding some costs beat analyst ...
502254
The European Medicines Agency has  recommended conditional approval of GlaxoSmithKline Plc's new  breast cancer pill Tykerb, Europe's biggest drugmaker said on  Friday.
680034
An executive of the company that makes the diabetes drug Avandia said a researcher who was among the first to link it to heart problems would be held liable for the $4 billion GlaxoSmithKline PLC lost in stock value as a result of his findings, Dr. John B. Buse testified before congressional investigators yesterday.
500250
GlaxoSmithKline&#39;s  experimental  platelet-boosting drug eltrombopag has produced further  positive results in patients with idiopathic thrombocytopenia  purpura (ITP), researchers said on Saturday.
697831
GlaxoSmithKline's  experimental platelet-boosting drug eltrombopag has produced further positive results in patients with idiopathic thrombocytopenia purpura (ITP), researchers said on Saturday.
476254
GlaxoSmithKline Plc, Europe&#39;s largest drugmaker, said it settled a lawsuit filed by New York Attorney General Eliot Spitzer, who accused the drugmaker last June of withholding safety data on the antidepressant Paxil.
477715
Pharmaceutical group GlaxoSmithKline (GSK) has agreed to buy antibody therapy developer Domantis for 230 million pounds.
457209
Akzo Nobel  said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough  for 11 billion euros ($14.4 billion), in a last-minute reversal of plans to float it on the stock market.
594161
Genzyme announces positive study results with a recently acquired drug.
336171
YESTERDAY Close $75.73 Change +$2.22 52-WEEK High $76.90 Low $58.71 Genzyme Corp. of Cambridge said profit jumped tenfold as sales increased for its medicines for rare genetic disorders, some of the world's costliest drugs. The company gained 3 percent in New York trading.
770040
An experimental antibody drug being developed by Danish biotech company Genmab and Britain's GlaxoSmithKline Plc confirmed its promise as a rheumatoid arthritis treatment on Friday.
670417
PARIS Sanofi-SynthÃ©labo, which this month completed its $63 billion purchase of a rival drug manufacturer, Aventis, reported Tuesday a 21 percent jump in first-half profit on higher demand for the blood thinner Plavix and the cancer treatment Eloxatin.
39231
Shares of SuperGen Inc. SUPG.O  jumped more than 24 percent in trading before the market opened  on Wednesday after MGI Pharma Inc. MOGN.O said it would take  a $40 million stake in the company as part of a cancer drug  license deal.